32
Views
4
CrossRef citations to date
0
Altmetric
Case Report

Effective high intensity focused ultrasound treatment in recurrent aggressive breast fibromatosis: a case report

, , , &
Pages 5251-5256 | Published online: 02 Jul 2019

References

  • Otero S, Moskovic EC, Strauss DC, et al. Desmoid-type fibromatosis. Clin Radiol. 2015;70(9):1038–1045. doi:10.1016/j.crad.2015.04.01526162574
  • Glazebrook KN, Reynolds CA. Mammary fibromatosis. AJR Am J Roentgenol. 2009;193(3):856–860. doi:10.2214/AJR.08.189219696302
  • Schwarz GS, Drotman M, Rosenblatt R, Milner L, Shamonki J, Osborne MP. Fibromatosis of the breast: case report and current concepts in the management of an uncommon lesion. Breast J. 2006;12(1):66–71. doi:10.1111/j.1075-122X.2006.00187.x16409590
  • Martinez Trufero J, Pajares Bernad I, Torres Ramon I, Hernando Cubero J, Pazo Cid R. Desmoid-type fibromatosis: who, when, and how to treat. Curr Treat Options Oncol. 2017;18(5):29. doi:10.1007/s11864-017-0474-028439797
  • Scheer L, Lodi M, Moliere S, Kurtz JE, Mathelin C. Medical treatment of mammary desmoid-type fibromatosis: which benefit? World J Surg Oncol. 2017;15(1):86. doi:10.1186/s12957-017-1148-x28420393
  • Rombouts SJ, Vogel JA, van Santvoort HC, et al. Systematic review of innovative ablative therapies for the treatment of locally advanced pancreatic cancer. Br J Surg. 2015;102(3):182–193. doi:10.1002/bjs.971625524417
  • Lang BH, Woo YC, Chiu KW. Role of second high-intensity focused ultrasound (HIFU) treatment for unsatisfactory benign thyroid nodules after first treatment. Eur Radiol. 2019;29(3):1469–1478.
  • Aubry JF, Pauly KB, Moonen C, et al. The road to clinical use of high-intensity focused ultrasound for liver cancer: technical and clinical consensus. J Ther Ultrasound. 2013;1:13. doi:10.1186/2050-5736-1-1325512859
  • Chen W, Zhu H, Zhang L, et al. Primary bone malignancy: effective treatment with high-intensity focused ultrasound ablation. Radiology. 2010;255(3):967–978. doi:10.1148/radiol.1009037420501734
  • Ghanouni P, Dobrotwir A, Bazzocchi A, et al. Magnetic resonance-guided focused ultrasound treatment of extra-abdominal desmoid tumors: a retrospective multicenter study. Eur Radiol. 2017;27(2):732–740. doi:10.1007/s00330-016-4376-527147222
  • Shi Y, Huang Y, Zhou M, Ying X, Hu X. High-intensity focused ultrasound treatment for intra-abdominal desmoid tumors: a report of four cases. J Med Ultrason (2001). 2016;43(2):279–284. doi:10.1007/s10396-015-0682-927033872
  • Wang Y, Wang W, Tang J. Ultrasound-guided high intensity focused ultrasound treatment for extra-abdominal desmoid tumours: preliminary results. Int J Hyperthermia. 2011;27(7):648–653. doi:10.3109/02656736.2011.59704721797696
  • Zhao WP, Han ZY, Zhang J, et al. Early experience: high-intensity focused ultrasound treatment for intra-abdominal aggressive fibromatosis of failure in surgery. Br J Radiol. 2016;89(1062):20151026. doi:10.1259/bjr.2015102627052682
  • Hu X, Cai H, Zhou M, et al. New clinical application of high-intensity focused ultrasound: local control of synovial sarcoma. World J Surg Oncol. 2013;11:265. doi:10.1186/1477-7819-11-26524103491
  • Grimaldi MC, Trentin C, Lo Gullo R, Cassano E. Fibromatosis of the breast mimicking cancer: a case report. Radiol Case Rep. 2018;13(1):1–5. doi:10.1016/j.radcr.2017.09.01129487630
  • Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA. Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol. 1999;17(1):158–167. doi:10.1200/JCO.1999.17.1.15810458229
  • Povoski SP, Marsh WL Jr., Spigos DG, Abbas AE, Buchele BA. Management of a patient with multiple recurrences of fibromatosis (desmoid tumor) of the breast involving the chest wall musculature. World J Surg Oncol. 2006;4:32. doi:10.1186/1477-7819-4-3216768799
  • Bonvalot S, Ternes N, Fiore M, et al. Spontaneous regression of primary abdominal wall desmoid tumors: more common than previously thought. Ann Surg Oncol. 2013;20(13):4096–4102. doi:10.1245/s10434-013-3197-x24052312
  • NCCN cIinical practice guideline for sarcoma  2018 Version 2. Available from:https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf. Accessed June 10, 2019 .
  • Kasper B, Baumgarten C, Garcia J, et al. An update on the management of sporadic desmoid-type fibromatosis: a European consensus initiative between Sarcoma PAtients EuroNet (SPAEN) and European Organization for research and treatment of cancer (EORTC)/Soft Tissue and Bone Sarcoma Group (STBSG). Ann Oncol. 2017;28(10):2399–2408. doi:10.1093/annonc/mdx32328961825
  • Janssen ML, van Broekhoven DL, Cates JM, et al. Meta-analysis of the influence of surgical margin and adjuvant radiotherapy on local recurrence after resection of sporadic desmoid-type fibromatosis. Br J Surg. 2017;104(4):347–357. doi:10.1002/bjs.1047728199014
  • Keus RB, Nout RA, Blay JY, et al. Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis–an EORTC STBSG and ROG study (EORTC 62991-22998). Ann Oncol. 2013;24(10):2672–2676. doi:10.1093/annonc/mdt25423868907
  • Bates JE, Morris CG, Iovino NM, et al. Radiation therapy for aggressive fibromatosis: the association between local control and age. Int J Radiat Oncol Biol Phys. 2018;100(4):997–1003. doi:10.1016/j.ijrobp.2017.12.25929485080
  • Plaza MJ, Yepes M. Breast fibromatosis response to tamoxifen: dynamic MRI findings and review of the current treatment options. J Radiol Case Rep. 2012;6(3):16–23. doi:10.3941/jrcr.v6i3.897
  • Zhou Y. High-intensity focused ultrasound treatment for advanced pancreatic cancer. Gastroenterol Res Pract. 2014;2014:205325. doi:10.1155/2014/20532525053938
  • Chaussy CG, Thuroff S. High-intensity focused ultrasound for the treatment of prostate cancer: a review. J Endourol. 2017;31(S1):S30–S37. doi:10.1089/end.2016.054828355119
  • Devos B, Al Hajj Obeid W, Andrianne C, et al. Salvage high-intensity focused ultrasound versus salvage radical prostatectomy for radiation-recurrent prostate cancer: a comparative study of oncological, functional, and toxicity outcomes. World J Urol. 2019. doi:10.1007/s00345-019-02640-x.